Gardasil news from FierceVaccines
NewsWhat's stopping girls from getting the HPV jab?
The controversial HPV vaccine has been making only slow progress in the U.S. Despite the fact that half of all girls are exposed to the virus--and 4,000 die each year from the cancer that it Read more...
Critics accuse Merck of hyping cervical cancer risk
Just how important Gardasil has become to Merck's top line is underscored by a New York Times article analyzing the impact of what the pharma company calls "educational programs" and just about Read more...
Study examines cost-effectiveness of Gardasil
A new study in the New England Journal of Medicine questions the cost-effectiveness of Gardasil in older women, saying that the payback is reduced by their increased exposure to the virus that causes Read more...
CDC details side effects reported on Gardasil
The CDC says there have been about 8,000 reported incidents of adverse effects due to Gardasil vaccinations in the U.S. More than 11 million doses of Gardasil were distributed last year. The most Read more...
Wall Street shrugs off FDA’s Gardasil rejection
Many Wall Street analysts greeted the FDA's decision to reject Merck's bid to expand the use of Gardasil to 27 to 45-year-old women with a yawn. For many on Wall Street, the key market for the Read more...
UK health officials in cancer vaccine fight
When British health officials weighed the benefits of the two cervical cancer vaccines, they concluded that Cervarix from GlaxoSmithKline provided the best value for the money. And that decision Read more...
| Press ReleasesPRESS RELEASE: Merck's GARDASIL and JANUVIA Receive Prix Galien USA Top Honors Merck's GARDASIL and JANUVIA Receive Prix Galien USA Top Honors Merck Products Named Best Biotechnology Product and Best Pharmaceutical Agent Former Merck CEO P. Roy Vagelos, M.D., Receives Pro Bono Read more... |
Get more Gardasil coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets